AIM-501

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameAIM-501
Drug Alias NameEp1B (AIM Therapeutics)AIM-501
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionImmunomodulators
TargetsUpdating
Therapy Area/IndicationsDiabetes Mellitus, Type 1Coronary Restenosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Western Ontario
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 1Coronary Restenosis

Other Information

ATC CodeN/A
Related LinksN/A